TM Module anaesthesia monitor displays two spectral entropybased indices, response entropy (RE) and state entropy (SE). The difference between RE and SE (RE2SE), which mainly reflects electromyography activation, is thought to indicate the adequacy of antinociception. Little is known, however, about the effects of neuromuscular blocking agents on the RE2SE. We investigated the effects of rocuronium on the RE2SE response to tracheal intubation.
Electroencephalographic (EEG) signals are used to monitor anaesthetic depth. Spectral entropy is one method of estimating the depth of anaesthesia. 1 Spectral entropy is determined by analysing EEG and frontal electromyogram (EMG) data and provides two indices, response entropy (RE) and state entropy (SE). SE, which is calculated over frequencies ranging from 0.8 to 32 Hz, is the entropy of the EEG signal, reflecting the patient's cortical activity. RE includes additional higher frequencies up to 47 Hz, and reflects both EEG and frontal EMG activities. The difference between RE and SE (RE2SE) mainly reflects EMG activation. 2 RE and RE2SE increase in response to noxious stimulation and are thought to be indicators of the adequacy of antinociception. 3 Neuromuscular blocking drugs (NMBDs), which decrease stretch receptor activity in the muscles and suppress stimulation input to the arousal centres in the brain, have a suppressive effect on EEG-derived indices. EMG activation by noxious stimulation, however, contaminates the EEG power spectrum and increases the bispectral index (BIS). 4 5 NMBDs decrease EMG activation and suppress the BIS and entropy response to noxious stimulation. 6 Although facial muscles are more resistant than other skeletal muscles to neuromuscular block, 7 8 high doses of NMBDs will also suppress facial muscle activity. We previously reported that the increase in RE2SE after tracheal intubation was not abolished, even when using vecuronium bromide. 9 Rocuronium suppresses the increase in the RE during laryngoscopy. 6 The difference in the degree of facial muscle paralysis may account for this discrepancy, but little is known about the dose effect of NMBDs on the RE2SE response to noxious stimulation. In the present study, we investigated the dose effect of rocuronium on the RE2SE response to tracheal intubation. We hypothesized that an increase in the rocuronium dose would suppress the tracheal intubation-induced increase in the RE2SE.
Methods
The study was approved by the Ethics Committee of the National Defense Medical College (Saitama, Japan), and informed consent was obtained from 44 patients, ASA physical status I-II, 20-69 yr of age, undergoing elective surgery. Exclusion criteria included disease or injury affecting the central nervous system, recent use of psychoactive or analgesic medication, neurologic disorders, alcohol or drug abuse, and weight ,70% or .130% of ideal body weight.
Premedication was not given before inducing general anaesthesia. Patients were randomly assigned to one of the four rocuronium dose groups (0.3, 0.6, 0.9, or 1.2 mg kg
21
). After the patients entered the operation theatre, ECG, non-invasive arterial pressure, heart rate (HR), and pulse oximetry were performed. An epidural catheter was inserted if necessary, but it was not used until completion of the study period. Anaesthesia was induced by propofol target-controlled infusion (TCI; a target plasma concentration of 6 mg ml 21 ) using a Diprifusor TCI pump (Terumo Corporation, Tokyo, Japan) based on the kinetic studies of Marsh and colleagues. 10 Ventilation was controlled to maintain end-tidal CO 2 at 35-40 mm Hg with a fresh gas flow of 6 litre min 21 (100% oxygen) via face mask. Ninety seconds after anaesthesia induction, the target concentration of propofol was reduced to 4 mg ml
. Two minutes after anaesthesia induction, rocuronium was administered (0.3, 0.6, 0.9, or 1.2 mg kg
). Seven minutes after anaesthesia induction, tracheal intubation was performed. Tracheal intubation was defined as the time at which the cuff was inflated. To avoid awareness during the study period, patients were excluded when the BIS was .65 before tracheal intubation. Patients in whom tracheal intubation could not be performed within 1 min were also excluded.
Non-invasive mean arterial pressure (MAP) and HR were recorded every minute from the beginning of propofol infusion. BIS, RE, and SE values just before tracheal intubation and the maximum values within 5 min after tracheal intubation were recorded. Patient movement (movement of arms, legs, or head) during or after tracheal intubation was also recorded by an investigator blinded to the study protocol.
Non-invasive arterial pressure monitoring, electrocardiography, pulse oximetry, and end-tidal CO 2 monitoring were performed with a Datex-Ohmeda S/5 TM anaesthesia monitor (GE Healthcare, Helsinki, Finland). BIS was monitored with a BIS XP Monitor (ver. 3.4) with a quarto sensor (Aspect Medical Systems, Norwood, MA, USA). The smoothing time was 15 s. RE and SE were monitored with a Datex-Ohmeda S/5 Entropy Module (M-Entropy TM ) and an Entropy Sensor TM (GE-Healthcare). Both sensors were applied side by side to the forehead following the manufacturer's recommendations. All data were captured offline with a digital video camera (Matsushita Electrical Industrial, Osaka, Japan) and recorded by an investigator blinded to the study protocol.
Differences in sex were analysed with the x 2 test. Differences in age, weight, and height between the groups were analysed with the Kruskal -Wallis test. Changes in MAP, HR, BIS, RE, SE, and RE2SE within the groups ( pre-intubation vs maximum values within 5 min after intubation) were analysed with the Wilcoxon test. Differences in MAP, HR, BIS, RE, SE, and RE2SE between the groups were analysed with the KruskalWallis test followed by Dunn's multiple comparisons test. Differences in BIS, RE, SE, and RE2SE between movers and non-movers were analysed with a Mann -Whitney U-test. Differences in the incidence of the decrease in EEG indices after tracheal intubation were analysed with the x 2 test. The number of patients is indicated by n. A P-value of ,0.05 was considered statistically significant. All data are presented as median (range).
Results
Patient characteristics are summarized in Table 1 . No difference was observed between the groups. One patient 159 (4) 164 (6) 163 (7) 161 (8) in the rocuronium 0.6 mg kg 21 group was excluded because the BIS was .65 just before tracheal intubation. One patient in the rocuronium 0.3 mg kg 21 group and two patients in the rocuronium 0.9 mg kg 21 group were excluded because tracheal intubation could not be performed within 1 min. In the postoperative recovery room and the next day, patients were questioned with respect to perioperative memory, but no intraoperative awareness or recall was reported.
Before tracheal intubation, there was no significant difference in BIS, RE, SE, and RE2SE between the groups (Table 2 ). All EEG indices increased after tracheal intubation. The maximum increase in EEG indices after tracheal intubation is shown in Figure 1 . The increase in Table 2 Changes in MAP, HR, EEG indices, and incidence of movement. MAP, mean arterial pressure; HR, heart rate; BIS, bispectral index; RE, response entropy; SE, state entropy; Pre-intubation, values before tracheal intubation; Post-intubation, maximum values after tracheal intubation; Mover, patient who moved during or after tracheal intubation; Non-mover, patient who did not move during or after tracheal intubation. Values are median (range). * and ** indicate P,0.05 and ,0.01 vs pre-intubation. BIS, RE, SE, and RE2SE after tracheal intubation was suppressed with an increase in the rocuronium dose. After tracheal intubation, BIS decreased in zero, zero, one, and four patients in the rocuronium 0.3, 0.6, 0.9, and 1.2 mg kg 21 groups, respectively; RE decreased in zero, one, zero, and two patients, respectively; SE decreased in zero, one, two, and two patients, respectively; and RE2SE decreased in none of the patients. The incidence of a decrease in BIS increased with an increase in the rocuronium dose (P¼0.02).
In the rocuronium 0.3, 0.6, and 0.9 mg kg 21 groups, nine, three, and one patient, respectively, moved (movers) in response to tracheal intubation, but none of the patients in the rocuronium 1.2 mg kg 21 group moved (nonmovers). After tracheal intubation, among movers (n¼13), the following parameters were significantly increased: BIS from 52 (31 -60) to 68 (56 -81), RE from 54 (24 -62) to 82 (42 -100), SE from 52 (23 -62) to 70 (38 -87), and RE2SE from 1 (0 -4) to 13 (2-21). Among non-movers (n¼26), the following parameters were significantly increased: BIS from 46 (30 -61) to 49 (33 -65), RE from 51 (25-66) to 58 (26 -78), SE from 51 (25 -64) to 56 (26 -72), and RE2SE from 1 (0 -4) to 3 (0 -6). The increases in BIS, RE, SE, and RE2SE after tracheal intubation among movers were significantly greater than those among non-movers (Fig. 2) .
In all groups, MAP and HR increased after tracheal intubation compared with before intubation, but there was no significant difference in MAP and HR between the groups (Table 2) .
Discussion
The BIS, RE, and SE values increased after tracheal intubation. Patients moved after tracheal intubation and the incidence of movement decreased with an increase in the rocuronium dose. The increases in BIS, RE, SE, and RE2SE after tracheal intubation in movers were significantly greater than those in non-movers. The increase in all EEG-derived indices after tracheal intubation was suppressed by an increase in the rocuronium dose. The RE2SE values increased after tracheal intubation and this increase in RE2SE was also suppressed by increasing the dose of rocuronium.
The RE2SE value reflects EMG activity. Facial muscles are more resistant than other skeletal muscles to NMBD 7 8 and noxious stimulation increases RE2SE values, even when NMBD is used. 9 The increase in RE during laryngoscopy is abolished, however, by rocuronium administration. 6 Therefore, we hypothesized that the degree of muscle paralysis affects RE2SE values. In the present study, rocuronium suppressed the increase in RE2SE after tracheal intubation in a dose-dependent manner without suppressing MAP and HR. These findings suggest that rocuronium suppresses RE2SE without an antinociceptive effect and that the degree of RE2SE may not correlate with antinociception in different states of muscle paralysis. When NMBDs are used during general anaesthesia, estimations of nociception using RE2SE should be interpreted carefully because NMBDs affect the RE2SE value. , RE (C), and difference between RE and SE (RE2SE, D) after tracheal intubation in movers and non-movers. Box indicates median, 25% (box top), and 75% (box bottom), and whiskers indicate range. Mover is the patient who moved during or after tracheal intubation; non-mover is the patient who did not move during or after tracheal intubation.**P,0.01 vs non-mover group.
In the present study, BIS and SE values also increased after tracheal intubation and the increase in BIS and SE was suppressed by an increase in the rocuronium dose. Furthermore, the increases in BIS and SE values in movers were significantly greater than those in non-movers. These findings indicate that increased BIS and SE values after tracheal intubation might be due to EMG contamination and that both BIS and SE are affected by EMG activity because the power spectrum of EMG overlaps that of EEG. Some studies report a significant increase in BIS in response to tracheal intubation during propofol anaesthesia. 6 11 12 The increase in BIS after tracheal intubation is controversial, however, because it has also been reported that BIS values do not significantly increase after tracheal intubation. 13 One possible reason for the discrepancy is that a different degree of muscle paralysis was induced. The increase in all EEG indices after tracheal intubation was almost abolished in the rocuronium 1.2 mg kg 21 group. This finding suggests that the increase in the EEG indices after tracheal intubation mainly reflected EMG activation and tracheal intubation led to little cortical arousal (lightening hypnosis) in our patients. Antinociceptive drugs, however, should be used to avoid cortical arousal when hypnotic agents are titrated or intensive stimulation is needed due to difficulties intubating the patient.
In previous studies, BIS decreased in some patients after noxious stimulation with delta wave activation, which is called 'paradoxical arousal'. 14 15 In the present study, BIS decreased in zero, zero, one, and four patients in the rocuronium 0.3, 0.6, 0.9, and 1.2 mg kg 21 groups. It is unclear whether paradoxical arousal occurred in the patients because raw EEG wave or delta wave activity was not recorded in the present study. Although the correlation between the incidence of paradoxical arousal and the degree of muscle paralysis is not known, the incidence of a decrease in BIS increased with an increase in the rocuronium dose. Therefore, paradoxical arousal may easily occur under deep muscle paralysis. It is unclear whether delta wave activation occurred, even in the low rocuronium dose groups. The lack of a decrease in BIS in the low rocuronium dose groups in the present study may have been due to an increase in EMG activity that masked the paradoxical arousal.
NMBDs have a hypnotic effect per se because the stretch receptor activity in the muscles, which stimulate the arousal centres in the brain, is suppressed by NMBDs. 4 Therefore, it is possible that rocuronium decreased the arousal stimulation from stretch receptor activity and suppressed the increase in the EEG indices after tracheal intubation. BIS level and EMG tone are reportedly not affected by NMBD administration during propofol anaesthesia 16 and, in the present study, there was no significant difference in the EEG values just before tracheal intubation between the groups, suggesting that the suppressive effect of rocuronium on hypnosis contributed little to our findings.
The present study has some limitations. The dosedependent effects of rocuronium on EEG indices were studied, but data for patients with a rocuronium dose of 0 mg kg 21 (Control) were not collected because we could not perform tracheal intubation safely without muscle paralysis due to excessive patient movement. Furthermore, the degree of muscle paralysis was not monitored because electrical stimulation is noxious per se and may affect the EEG-derived indices after tracheal intubation. The correlation between the degree of muscle paralysis and EEG indices is therefore uncertain. In addition, although neuromuscular block level does not alter BIS and EMG activity during propofol anaesthesia in the absence of noxious stimuli, 16 it is not known whether EMG activity increased during or after tracheal intubation because EMG activity, such as the EMG index of the BIS monitor, was not recorded in the present study. Therefore, the association between decreasing EMG activity and suppression of EEG indices in the presence of noxious stimuli is based on indirect observations in the present study.
In conclusion, the RE2SE value increased after tracheal intubation and the increase in RE2SE was suppressed by an increase in the rocuronium dose. Although RE2SE is suggested to be a potential surrogate indicator of the adequacy of antinociception, the degree of muscle paralysis may affect the RE2SE value and estimates of nociception based on RE2SE values should be interpreted carefully in different states of muscle paralysis during general anaesthesia.
